Professor, Department of Cardiovascular & Thoracic Surgery
Professor, Department of Surgery
Chair, Department of Cardiovascular & Thoracic Surgery
Chair, Department of Surgery
Samuel Belkin Professorial Chair (YU)
Co-Director, Montefiore Einstein Center for Heart and Vascular Care
Robert E. Michler, MD, an internationally renowned cardiothoracic surgeon and researcher, a leader in several subspecialties, including complex cardiac surgery, heart transplantation, valve repair surgery, ventricular reconstruction for congestive heart failure and minimally invasive cardiac surgery. Of particular note, Dr. Michler was one of the first to perform minimally invasive and robotic surgery in heart patients. His pivotal work in robotics led to Food and Drug Administration (FDA) approval of this advanced technology for mitral valve repair and coronary artery bypass surgery. And as the lead investigator in groundbreaking FDA trials, he is pioneering the safe use of injections of autologous human muscle cells and stem cells into diseased heart muscle to treat heart failure. Dr. Michler’s vision for the future includes developing new surgical approaches that re-define state-of-the-art care through heart remodeling, surgery for valve repair and treatment of atrial fibrillation, minimally invasive and robotic surgery, heart assist devices and heart transplants, stem cell research and myoblast injections.
Williams JB, Peterson ED, Brennan JM, Sedrakyan A, Tavris D, Alexander JH, Lopes RD, Dokholyan RS, Zhao Y, O’Brien SM, Michler RE, Thourani VH, Edwards FH, Gross T, Marinac-Dabic D, Smith PK. Endoscopic Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308(5):475-84.
Michler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Velazquez EJ, Lee KL, Di Donato M. Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg. 2013;146(5):1139-1145.
Michler RE. Surgical Options for the Management of Ischemic Cardiomyopathy.Current Treatment Options in Cardiovascular Medicine. 2013;15(5):518-532.
Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, Smith PK, Hung JW, Blackstone EH, Puskas JD, Argenziano M, Gammie JS, Mack M, Ascheim DD, Bagiella E, Moquete EG, Ferguson TB, Horvath KA, Geller NL, Miller MA, Woo YJ, D'Alessandro DA, Ailawadi G, Dagenais F, Gardner TJ, O'Gara PT, Michler RE, Kron IL; the CTSN Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. N Engl J Med. 2014;370(1):23-32.
Michler RE. Stem cell therapy for heart failure. Cardiol Rev. 2014;22(3):105-16.
Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371(23):2178-88.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.
Montefiore Medical Center
111 East 210th Street
MMC-MAP, Room 5B
Bronx, NY 10467
The New York Times interviews Dr. Robert Michler about former Vice President Dick Cheney's heart transplant, the donor match process and the important recovery milestones for this surgery.
MD News (Lower Hudson/Bronx) profiles the Montefiore Einstein Center for Heart and Vascular Care for its cover feature. The article includes interviews with the center’s co-directors, Robert Michler, M.D., and Mario Garcia, M.D.